Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG10355)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
AGPAT3
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Unspecific Target [Unspecific Target]
In total 1 item(s) under this target | |||||
Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | ||||
Responsed Disease | Hereditary Leiomyomatosis | ICD-11: 2C90 | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell Process | Cell ferroptosis | ||||
In Vitro Model |
786-O cells | Renal cell carcinoma | Homo sapiens | CVCL_1051 | |
769-P cells | Renal cell carcinom | Homo sapiens | CVCL_1050 | ||
SNU-685 cells | Uterine carcinosarcoma | Homo sapiens | CVCL_5083 | ||
Huh-7 cells | Hepatocellular carcinoma | Homo sapiens | CVCL_0336 | ||
HEK-293T cells | Normal | Homo sapiens | CVCL_0063 | ||
OVCAR-8 cells | High grade ovarian serous adenocarcinoma | Homo sapiens | CVCL_1629 | ||
SH-SY5Y cells | Neuroblastoma | Homo sapiens | CVCL_0019 | ||
In Vivo Model |
3-4 week-old, male athymic nude mice were used for hosting the 786-O tumor xenografts. In the experiment that leads to isolation of ferroptosis-resistant 1 (FR1) cells , 5 x 106 wildtype or GPX4-/-single-cell clone (originally named as #3A7 clone3, then renamed as ferroptosis-sensitive (FS) GPX4-/-cells in the present study) of 786-O-Cas9 cells were resuspended in 50 ul sterile PBS containing 50 uM Fer-1, mixed with 50 ul Matrigel (BD Biosciences), and subcutaneously injected into both flanks of the mouse.
Click to Show/Hide
|
||||
Response regulation | Using lipidomic analysis, we found that AGPAT3-depletion selectively reduced the levels of the polyunsaturated species among both ether-linked and diacyl-phospholipids in renal cell carcinoma 786-O cells . Consistently, genetic AGPAT3-depletion suppressed sensitivity to ferroptosis. | ||||
Hereditary Leiomyomatosis [ICD-11: 2C90]
In total 1 item(s) under this disease | |||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | ||||
Target Regulator | 1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (AGPAT3) | Protein coding | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell Process | Cell ferroptosis | ||||
In Vitro Model |
786-O cells | Renal cell carcinoma | Homo sapiens | CVCL_1051 | |
769-P cells | Renal cell carcinom | Homo sapiens | CVCL_1050 | ||
SNU-685 cells | Uterine carcinosarcoma | Homo sapiens | CVCL_5083 | ||
Huh-7 cells | Hepatocellular carcinoma | Homo sapiens | CVCL_0336 | ||
HEK-293T cells | Normal | Homo sapiens | CVCL_0063 | ||
OVCAR-8 cells | High grade ovarian serous adenocarcinoma | Homo sapiens | CVCL_1629 | ||
SH-SY5Y cells | Neuroblastoma | Homo sapiens | CVCL_0019 | ||
In Vivo Model |
3-4 week-old, male athymic nude mice were used for hosting the 786-O tumor xenografts. In the experiment that leads to isolation of ferroptosis-resistant 1 (FR1) cells , 5 x 106 wildtype or GPX4-/-single-cell clone (originally named as #3A7 clone3, then renamed as ferroptosis-sensitive (FS) GPX4-/-cells in the present study) of 786-O-Cas9 cells were resuspended in 50 ul sterile PBS containing 50 uM Fer-1, mixed with 50 ul Matrigel (BD Biosciences), and subcutaneously injected into both flanks of the mouse.
Click to Show/Hide
|
||||
Response regulation | Using lipidomic analysis, we found that AGPAT3-depletion selectively reduced the levels of the polyunsaturated species among both ether-linked and diacyl-phospholipids in renal cell carcinoma 786-O cells . Consistently, genetic AGPAT3-depletion suppressed sensitivity to ferroptosis. | ||||